151 related articles for article (PubMed ID: 34262350)
1. Quantitative Analysis and Pathological Basis of Signal Intensity on T2-Weighted MR Images in Benign and Malignant Parotid Tumors.
Wei P; Shao C; Tian M; Wu M; Wang H; Han Z; Hu H
Cancer Manag Res; 2021; 13():5423-5431. PubMed ID: 34262350
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of maximum signal intensity on T1-weighted MRI images for differentiating parotid gland tumours along with pathological correlation.
Wei PY; Shao C; Huan T; Wang HB; Ding ZX; Han ZJ
Clin Radiol; 2021 Jun; 76(6):472.e19-472.e25. PubMed ID: 33731262
[TBL] [Abstract][Full Text] [Related]
3. Differentiating parotid tumors by quantitative signal intensity evaluation on MR imaging.
Matsusue E; Fujihara Y; Matsuda E; Tokuyasu Y; Nakamoto S; Nakamura K; Ogawa T
Clin Imaging; 2017; 46():37-43. PubMed ID: 28704680
[TBL] [Abstract][Full Text] [Related]
4. Intravoxel Incoherent Motion Magnetic Resonance Imaging for Assessing Parotid Gland Tumors: Correlation and Comparison with Arterial Spin Labeling Imaging.
Ma G; Xu XQ; Zhu LN; Jiang JS; Su GY; Hu H; Bu SS; Wu FY
Korean J Radiol; 2021 Feb; 22(2):243-252. PubMed ID: 32932565
[TBL] [Abstract][Full Text] [Related]
5. Amide proton transfer-weighted magnetic resonance imaging for the differentiation of parotid gland tumors.
Wang Y; Wang L; Huang H; Ma J; Lin L; Liu L; Song Q; Liu A
Front Oncol; 2023; 13():1223598. PubMed ID: 37664057
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of parotid pleomorphic adenoma from Warthin tumor using signal intensity ratios on fat-suppressed T2-weighted magnetic resonance imaging.
Lin W; Ye W; Ma J; Wang S; Chen P; Yang Y; Yin B
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Mar; 137(3):310-319. PubMed ID: 38195353
[TBL] [Abstract][Full Text] [Related]
7. Tumor blood flow and apparent diffusion coefficient histogram analysis for differentiating malignant salivary tumors from pleomorphic adenomas and Warthin's tumors.
Tanaka F; Umino M; Maeda M; Nakayama R; Inoue K; Kogue R; Obara M; Sakuma H
Sci Rep; 2022 Apr; 12(1):5947. PubMed ID: 35396374
[TBL] [Abstract][Full Text] [Related]
8. Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings.
Yamamoto T; Kimura H; Hayashi K; Imamura Y; Mori M
Neuroradiology; 2018 Aug; 60(8):803-812. PubMed ID: 29968073
[TBL] [Abstract][Full Text] [Related]
9. Value of pre-/post-contrast-enhanced T1 mapping and readout segmentation of long variable echo-train diffusion-weighted imaging in differentiating parotid gland tumors.
Wen B; Zhang Z; Fu K; Zhu J; Liu L; Gao E; Qi J; Zhang Y; Cheng J; Qu F; Zhu J
Eur J Radiol; 2023 May; 162():110748. PubMed ID: 36905715
[TBL] [Abstract][Full Text] [Related]
10. Influence of post-label delay time on the performance of 3D pseudo-continuous arterial spin labeling magnetic resonance imaging in the characterization of parotid gland tumors.
Hu H; Chen L; Zhu LN; Chen W; Su GY; Dou W; Bu SS; Wu FY; Xu XQ
Eur Radiol; 2022 Feb; 32(2):1087-1094. PubMed ID: 34347158
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric approach with synthetic MR imaging for diagnosing salivary gland lesions.
Takumi K; Nakanosono R; Nagano H; Hakamada H; Kanzaki F; Kamimura K; Nakajo M; Eizuru Y; Nagano H; Yoshiura T
Jpn J Radiol; 2024 May; ():. PubMed ID: 38733471
[TBL] [Abstract][Full Text] [Related]
12. Quantitative dynamic contrast-enhanced MRI and readout segmentation of long variable echo-trains diffusion-weighted imaging in differentiating parotid gland tumors.
Huang N; Xiao Z; Chen Y; She D; Guo W; Yang X; Chen Q; Cao D; Chen T
Neuroradiology; 2021 Oct; 63(10):1709-1719. PubMed ID: 34241661
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of single-source dual-energy spectral computed tomography in differentiating parotid gland tumors: initial results.
Li L; Zhao Y; Luo D; Yang L; Hu L; Zhao X; Wang Y; Liu W
Quant Imaging Med Surg; 2018 Jul; 8(6):588-596. PubMed ID: 30140621
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Characteristics and CT Findings of Parotid and Submandibular Gland Tumours.
Zuo H
J Oncol; 2021; 2021():8874100. PubMed ID: 34306079
[TBL] [Abstract][Full Text] [Related]
15. Imaging quality of PROPELLER diffusion-weighted MR imaging and its diagnostic performance in distinguishing pleomorphic adenomas from Warthin tumors of the parotid gland.
Liu YJ; Lee YH; Chang HC; Chung HW; Wang CW; Juan CH; Chu YH; Lee JC; Juan CJ
NMR Biomed; 2020 May; 33(5):e4282. PubMed ID: 32124504
[TBL] [Abstract][Full Text] [Related]
16. Can Magnetic Resonance Radiomics Analysis Discriminate Parotid Gland Tumors? A Pilot Study.
Gabelloni M; Faggioni L; Attanasio S; Vani V; Goddi A; Colantonio S; Germanese D; Caudai C; Bruschini L; Scarano M; Seccia V; Neri E
Diagnostics (Basel); 2020 Nov; 10(11):. PubMed ID: 33153140
[TBL] [Abstract][Full Text] [Related]
17. Perfusion Computed Tomography Scan Imaging in Differentiation of Benign from Malignant Parotid Lesions.
Niazi M; Mohammadzadeh M; Aghazadeh K; Sharifian H; Karimi E; Shakiba M; Baniasadi M; Rahmaty B; Adel S; Moharreri M
Int Arch Otorhinolaryngol; 2020 Apr; 24(2):e160-e169. PubMed ID: 32256836
[No Abstract] [Full Text] [Related]
18. Perfusion imaging of parotid gland tumours: usefulness of arterial spin labeling for differentiating Warthin's tumours.
Kato H; Kanematsu M; Watanabe H; Kajita K; Mizuta K; Aoki M; Okuaki T
Eur Radiol; 2015 Nov; 25(11):3247-54. PubMed ID: 25921591
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of Benign From Malignant Parotid Gland Tumors Using Conventional MRI Based on Radiomics Nomogram.
Qi J; Gao A; Ma X; Song Y; Zhao G; Bai J; Gao E; Zhao K; Wen B; Zhang Y; Cheng J
Front Oncol; 2022; 12():937050. PubMed ID: 35898886
[TBL] [Abstract][Full Text] [Related]
20. Apparent Diffusion Coefficient Map-Based Radiomics Features for Differential Diagnosis of Pleomorphic Adenomas and Warthin Tumors From Malignant Tumors.
Wen B; Zhang Z; Zhu J; Liu L; Li Y; Huang H; Zhang Y; Cheng J
Front Oncol; 2022; 12():830496. PubMed ID: 35747827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
